This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction Note: Preclinical studies of toxicity and anti-cholangiocarcinoma activity of the standardized capsule formulation of atractylodes lancea (Thunb.) DC
Tullayakorn Plengsuriyakarn, Kanawut Kotawong, Juntra Karbwang, Kesara Na-Bangchang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCholangiocarcinoma and Gallbladder Cancer Studies · Berberine and alkaloids research · Traditional Chinese Medicine Analysis
**Retraction Note: BMC Complementary Medicine and Therapie s23, 186 (2023) **
https://doi.org/10.1186/s12906-023-03992-z
The Editor has retracted this article. After publication, concerns were raised regarding highly similar images within the article. Specifically:
• Fig. 1, Thymus (1000) and Fig. 2 Thymus (1000) appear to be highly similar.
• Fig. 1, Brain (1000) and Fig. 2 Brain (1000) appear to be highly similar.
• Fig. 4A, CMC-AL (medium dose) and CMC-AL (low dose) appear to partially overlap.
The authors have stated that the images were included by error but were unable to provide a sufficient response to the concerns raised, nor verifiable original images. Therefore, the Editor no longer has confidence in the presented data.
Tullayakorn Plengsuriyakarn, Kanawut Kotawong and Kesara Na-Bangchang disagree with this retraction.
Juntra Karbwang did not respond to correspondence from the Publisher about this retraction notice.